Keywords: columbia, starts, mrp, eu, striant, sr, firm
Columbia starts MRP in EU for Striant SR
Article | 05 July 2004
US firm Columbia Laboratories has initiated the European Union's MutualRecognition Procedure for its Striant SR, a testosterone replacement therapy for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
